In 2007, the West Coast Office hosted a series of events designed to create an advanced learning community to benefit the state's life sciences industry. These seminars featured thought leaders and senior executives from several of the region's premier biotech firms, who provided perspective about the latest developments, challenges, and solutions in drug development and quality control, as well as the adoption of advanced production techniques.
About Siddharth Advant
Prior to joining Tunnell, Siddharth Advant, Ph.D. was a Director for Diosynth Biotechnology, heading three primary areas: Project Management & Business Alliances, Technology Transfer & Clinical Operations, and Pharmaceutical Sciences & Stability. In these positions, Dr. Advant was responsible for technical and financial execution of customer projects, development and implementation of technology transfer, as well as building and managing an analytical, formulation and cGMP testing laboratory. He worked as a scientist in the pharmaceutical development division at Protein Design Labs, Inc. and as a Program Manager for BioReliance, Inc. where he supervised a cGMP/GLP compliant formulation development business.
Dr. Advant earned a B.S. degree in pharmacy from the University of
Poona, India and a Ph.D. in Pharmaceutics from the University of
Connecticut School of Pharmacy. He is a Founding Member of the CMC Strategy
Forum Advisory Committee, which consists of FDA and Industry members, and
served as Chair for the 2008 WCBP Meeting, 2004 AAPS National Biotechnology
Conference in Boston and the 2002 AAPS Biotechnology Section. The author of
various peer-reviewed articles, Dr. Advant has also made a number of
scientific presentations at major industry c
|SOURCE Tunnell Consulting|
Copyright©2008 PR Newswire.
All rights reserved